Role of Ferroportin in Macrophage-Mediated Immunity
Open accessAbstract
Perturbations in iron metabolism have been shown to dramatically impact host response to infection. The most common inherited iron overload disorder results from defects in the HFE gene product, a major histocompatibility complex class I-like protein that interacts with transferrin receptors. HFE-associated hemochromatosis is characterized by abnormally high levels of the iron efflux protein ferroportin. In this study, J774 murine macrophages overexpressing ferroportin were used to investigate the influence of iron metabolism on the release of nitric oxide (NO) in response to infection. Overexpression of ferroportin significantly impaired intracellular Mycobacterium tuberculosis growth during early stages of infection. When challenged with lipopolysaccharide (LPS) or M. tuberculosis infection, control macrophages increased NO synthesis, but macrophages overexpressing ferroportin had significantly impaired NO production in response to LPS or M. tuberculosis . Increased NO synthesis in control cells was accompanied by increased iNOS mRNA and protein, while upregulation of iNOS protein was markedly reduced when J744 cells overexpressing ferroportin were challenged with LPS or M. tuberculosis , thus limiting the bactericidal activity of these macrophages. The proinflammatory cytokine gamma interferon reversed the inhibitory effect of ferroportin overexpression on NO production. These results suggest a novel role for ferroportin in attenuating macrophage-mediated immune responses.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Ferroportin-mediated iron export is effective in macrophages infected with M. tuberculosis.
“This mechanism has also proven to be effective in macrophages infected with M. tuberculosis (183).”
From Macrophage defense mechanisms against intracellular bacteria (2015) · cites this paper as [183]
Overexpression of FPN1 decreases survival of the intracellular pathogen Mycobacterium tuberculosis.
“In line with these results overexpression of FPN1 resulted in decreased survival of the intracellular pathogen Mycobacterium tuberculosis [161].”
From Iron in immune cell function and host defense (2021) · cites this paper as [161]
Ferroportin overexpressing macrophages also have reduced iNOS production and phagocytic ability, suggesting that depletion of intracellular iron stores may interfere with macrophage effector functions.
“Interestingly, ferroportin overexpressing macrophages also have reduced inducible nitric oxide synthase (iNOS) production and phagocytic ability, suggesting that depletion of intracellular iron stores may interfere with macrophage effector functions [52].”
From Hepcidin and Host Defense against Infectious Diseases (2015) · cites this paper as [52]
Ferroportin overexpressing macrophages have lower mycobacterial burden as compared to normal macrophages when infected with M. tuberculosis in vitro.
“Ferroportin overexpressing macrophages have lower mycobacterial burden as compared to normal macrophages when infected with M. tuberculosis in vitro [52].”
From Hepcidin and Host Defense against Infectious Diseases (2015) · cites this paper as [52]
The detrimental effect of hepcidin in intracellular infections is not supported by in vivo data.
“but is not supported by in vivo data [32,39–43,49–55]”
From Hepcidin and Host Defense against Infectious Diseases (2015) · cites this paper as [52]
Hepcidin may be detrimental in host defense against pathogens that occupy the intracellular niche.
“may be detrimental in defense against pathogens that occupy this intracellular niche”
From Hepcidin and Host Defense against Infectious Diseases (2015) · cites this paper as [52]
The detrimental effect of hepcidin in intracellular infections has been demonstrated convincingly in vitro.
“This effect has been demonstrated convincingly in vitro”
From Hepcidin and Host Defense against Infectious Diseases (2015) · cites this paper as [52]
Hepcidin induces iron accumulation in macrophages.
“hepcidin induces iron accumulation in macrophages”
From Hepcidin and Host Defense against Infectious Diseases (2015) · cites this paper as [52]
In intramacrophage infections (S. Typhimurium, M. tuberculosis, M. avium), hepcidin is detrimental by promoting sequestration of iron in macrophages.
“Detrimental, by promoting sequestration of iron in macrophages”
From Hepcidin and Host Defense against Infectious Diseases (2015) · cites this paper as [52]
Cites
Analyzing real-time PCR data by the comparative CT method
Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190 · see citing works
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · see citing works
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J. D., Xie, Q. W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,184 · see citing works
Hentze, M. W., Muckenthaler, M. U., & Andrews, N. C. (2004) · Cell · doi:10.1016/s0092-8674(04)00343-5 · Cited by 1,736 · see citing works
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697 · see citing works
iNOS-mediated nitric oxide production and its regulation
Aktan, F. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.10.042 · Cited by 1,364 · see citing works
The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis
Donovan, A., Lima, C. A., Pinkus, J. L., Pinkus, G. S., Zon, L. I., Robine, S., & Andrews, N. C. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.01.003 · Cited by 1,275 · see citing works
A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism
Abboud, S., & Haile, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000713200 · Cited by 1,267 · see citing works
Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214 · see citing works
Chan, J., Xing, Y., Magliozzo, R. S., & Bloom, B. R. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.4.1111 · Cited by 1,062 · see citing works
Schaible, U. E., & Kaufmann, S. H. E. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1046 · Cited by 945 · see citing works
Andrews, N. C., & Schmidt, P. J. (2006) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.031905.164337 · Cited by 640 · see citing works
Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction
Corbett, J. A., Tilton, R. G., Chang, K. C., Hasan, K. S., Ido, Y., Wang, J. L., Sweetland, M. A., Lancaster, J. R., Williamson, J. R., & McDaniel, M. L. (1992) · Diabetes · doi:10.2337/diab.41.4.552 · Cited by 628 · see citing works
Wolf, A. J., Linas, B. S., Trevejo-Nuñez, G., Kincaid, E., Tamura, T., Takatsu, K., & Ernst, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2509 · Cited by 558 · see citing works
Knutson, M. D., Oukka, M., Koss, L. M., Aydemir, F., & Wessling-Resnick, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409409102 · Cited by 479 · see citing works
Self-citationSerum ferritin is derived primarily from macrophages through a nonclassical secretory pathway
Cohen, L. A., Gutierrez, L., Weiss, A., Leichtmann-Bardoogo, Y., Zhang, D.-L., Crooks, D. R., Sougrat, R., Morgenstern, A., Galy, B., Hentze, M. W., et al. (2010) · Blood · doi:10.1182/blood-2009-11-253815 · Cited by 452 · see citing works
Iron regulates nitric oxide synthase activity by controlling nuclear transcription.
Weiss, G., Werner-Felmayer, G., Werner, E. R., Grünewald, K., Wachter, H., & Hentze, M. W. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.969 · Cited by 412 · see citing works
Pietrangelo, A. (2003) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2003.08.003 · Cited by 380 · see citing works
TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens
Peyssonnaux, C., Zinkernagel, A. S., Datta, V., Lauth, X., Johnson, R. S., & Nizet, V. (2006) · Blood · doi:10.1182/blood-2005-06-2259 · Cited by 379 · see citing works
Iron Metabolism in the Reticuloendothelial System
Knutson, M. D., & Wessling‐Resnick, M. (2003) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/713609210 · Cited by 349 · see citing works
Self-citationIron imports. IV. Hepcidin and regulation of body iron metabolism
Ganz, T., & Nemeth, E. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00412.2005 · Cited by 347 · see citing works
Flesch, I. E. A., & Kaufmann, S. H. E. (1991) · Infection and Immunity · doi:10.1128/iai.59.9.3213-3218.1991 · Cited by 280 · see citing works
Glickstein, H., El, R. B., Shvartsman, M., & Cabantchik, Z. I. (2005) · Blood · doi:10.1182/blood-2005-02-0460 · Cited by 249 · see citing works
Ferroportin‐mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome
De Domenico, I., Vaughn, M. B., Li, L., Bagley, D., Musci, G., Ward, D. M., & Kaplan, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601409 · Cited by 235 · see citing works
The molecular basis of ferroportin-linked hemochromatosis
De Domenico, I., Ward, D. M., Nemeth, E., Vaughn, M. B., Musci, G., Ganz, T., & Kaplan, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503804102 · Cited by 230 · see citing works
Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis
Sow, F. B., Florence, W. C., Satoskar, A. R., Schlesinger, L. S., Zwilling, B. S., & Lafuse, W. P. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0407216 · Cited by 229 · see citing works
Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages
Knutson, M. D., Vafa, M. R., Haile, D. J., & Wessling-Resnick, M. (2003) · Blood · doi:10.1182/blood-2003-04-1250 · Cited by 227 · see citing works
Self-citationIron depletion limits intracellular bacterial growth in macrophages
Paradkar, P. N., De Domenico, I., Durchfort, N., Zohn, I., Kaplan, J., & Ward, D. M. (2008) · Blood · doi:10.1182/blood-2007-12-126854 · Cited by 216 · see citing works
Association of Pulmonary Tuberculosis with Increased Dietary Iron
Gangaidzo, I. T., Moyo, V. M., Mvundura, E., Aggrey, G., Murphree, N. L., Khumalo, H., Saungweme, T., Kasvosve, I., Gomo, Z. A. R., Rouault, T., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/323203 · Cited by 191 · see citing works
Nairz, M., Theurl, I., Ludwiczek, S., Theurl, M., Mair, S. M., Fritsche, G., & Weiss, G. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00942.x · Cited by 182 · see citing works
Specific iron chelators determine the route of ferritin degradation
De Domenico, I., Ward, D. M., & Kaplan, J. (2009) · Blood · doi:10.1182/blood-2009-05-224188 · Cited by 176 · see citing works
Bekker, L., Freeman, S. L., Murray, P. J., Ryffel, B., & Kaplan, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6728 · Cited by 169 · see citing works
Wang, L., Johnson, E. E., Shi, H. N., Walker, W. A., Wessling-Resnick, M., & Cherayil, B. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2723 · Cited by 159 · see citing works
Self-citationGordeuk, V., McLaren, C., MacPhail, A., Deichsel, G., & Bothwell, T. (1996) · Blood · doi:10.1182/blood.v87.8.3470.bloodjournal8783470 · Cited by 154 · see citing works
Interferon‐γ limits the availability of iron for intramacrophage <i>Salmonella typhimurium</i>
Nairz, M., Fritsche, G., Brunner, P., Talasz, H., Hantke, K., & Weiss, G. (2008) · European Journal of Immunology · doi:10.1002/eji.200738056 · Cited by 151 · see citing works
Hepcidin—A Peptide Hormone at the Interface of Innate Immunity and Iron Metabolism
Ganz, T. (2006) · Springer eBooks · doi:10.1007/3-540-29916-5_7 · Cited by 146 · see citing works
The Iron Efflux Protein Ferroportin Regulates the Intracellular Growth of<i>Salmonella enterica</i>
Chlosta, S., Fishman, D. S., Harrington, L., Johnson, E. E., Knutson, M. D., Wessling-Resnick, M., & Cherayil, B. J. (2006) · Infection and Immunity · doi:10.1128/iai.74.5.3065-3067.2006 · Cited by 145 · see citing works
Self-citationDomenico, I. D., Lo, E., Ward, D. M., & Kaplan, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900453106 · Cited by 143 · see citing works
Iron and Mycobacterium tuberculosis infection
Lounis, N., Truffot-Pernot, C., Grosset, J., Gordeuk, V. R., & Boelaert, J. R. (2001) · Journal of Clinical Virology · doi:10.1016/s1386-6532(00)00136-0 · Cited by 142 · see citing works
The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease.
Zohn, I. E., De Domenico, I., Pollock, A., Ward, D. M., Goodman, J. F., Liang, X., Sanchez, A. J., Niswander, L., & Kaplan, J. (2007) · Blood · doi:10.1182/blood-2007-01-066068 · Cited by 104 · see citing works
Nairz, M., Fritsche, G., Crouch, M.-L. V., Barton, H. C., Fang, F. C., & Weiss, G. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01337.x · Cited by 100 · see citing works
Pietrangelo, A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.05.013 · Cited by 99 · see citing works
O’Brien, L. M., Carmichael, J., Lowrie, D. B., & Andrew, P. W. (1994) · Infection and Immunity · doi:10.1128/iai.62.11.5187-5190.1994 · Cited by 98 · see citing works
Morris, K. R., Lutz, R. D., Choi, H.-S., Kamitani, T., Chmura, K., & Chan, E. D. (2003) · Infection and Immunity · doi:10.1128/iai.71.3.1442-1452.2003 · Cited by 98 · see citing works
Olakanmi, O., Schlesinger, L. S., & Britigan, B. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0606405 · Cited by 88 · see citing works
The SLC40 basolateral iron transporter family (IREG1/ferroportin/MTP1)
McKie, A. T., & Barlow, D. J. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-003-1102-3 · Cited by 86 · see citing works
Iron overload due to mutations in ferroportin.
Domenico, I. D., Ward, D. M., Musci, G., & Kaplan, J. (2006) · PubMed · Cited by 84 · see citing works
Lebrón, J. A., & Björkman, P. J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2842 · Cited by 83 · see citing works
Aktan, F.: iNOS-mediated nitric oxide production and its regulation. Life Sci. 75, 639-653
Aktan, F. (2004) · Cited by 82 · see citing works
Sato, K., Akaki, T., & Tomioka, H. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00554.x · Cited by 71 · see citing works
Kupffer cells modulate iron homeostasis in mice via regulation of hepcidin expression
Theurl, M., Theurl, I., Hochegger, K., Obrist, P., Subramaniam, N., van Rooijen, N., Schuemann, K., & Weiss, G. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0346-y · Cited by 69 · see citing works
The hereditary hemochromatosis gene (HFE)
Feder, J. N. (1999) · Immunologic Research · doi:10.1007/bf02786472 · Cited by 54 · see citing works
Molecular and clinical correlates in iron overload associated with mutations in ferroportin.
Domenico, I. D., Ward, D. M., Nemeth, E., Ganz, T., Corradini, E., Ferrara, F., Musci, G., Pietrangelo, A., & Kaplan, J. (2006) · PubMed · Cited by 48 · see citing works
Mycobacterium tuberculosis gene expression in macrophages
Dubnau, E., & Smith, I. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00090-x · Cited by 34 · see citing works
Effect of iron on the growth and siderophore production of mycobacteria.
Raghu, B., Sarma, G. R. K., & Venkatesan, P. (1993) · PubMed · Cited by 33 · see citing works
Mycobacterium tuberculosis infection: a rare late complication after cord blood hematopoietic SCT
de Assis, R. A., Kerbauy, F. R., Rodrigues, M., Seguro, F. S., Aranha, L. F. C., Fayad, L., Shpall, E. J., Lima, M. J. G. D., & Hamerschlak, N. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.379 · Cited by 31 · see citing works
Serafín-López, J., Chacón-Salinas, R., Muñoz-Cruz, S., Enciso-Moreno, J. A., Estrada-Parra, S., & Estrada-García, I. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01482.x · Cited by 30 · see citing works
Domenico, I. D., Lo, E., Ward, D. M., & Kaplan, J. (2010) · Blood · doi:10.1182/blood-2009-10-251306 · Cited by 15 · see citing works
Flagged first, then by citations
1 of the 59 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Macrophage defense mechanisms against intracellular bacteria
Weiss, G., & Schaible, U. E. (2015) · Immunological Reviews · doi:10.1111/imr.12266 · Cited by 989 · see citing works
Hepcidin and the iron-infection axis
Drakesmith, H., & Prentice, A. M. (2012) · Science · doi:10.1126/science.1224577 · Cited by 686 · see citing works
Drakesmith, H., Nemeth, E., & Ganz, T. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.006 · Cited by 638 · see citing works
Are Reactive Oxygen Species Always Detrimental to Pathogens?
Paiva, C. N., & Bozza, M. T. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5447 · Cited by 559 · see citing works
Cellular Metabolism and Macrophage Functional Polarization
Zhu, L., Zhao, Q., Yang, T., Ding, W., & Zhao, Y. X. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2014.969421 · Cited by 428 · see citing works
Iron in infection and immunity
Nairz, M., & Weiss, G. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100864 · Cited by 359 · see citing works
Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype.
Cairo, G., Recalcati, S., Mantovani, A., & Locati, M. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.03.007 · Cited by 312 · see citing works
Calder, P. C. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113001286 · Cited by 283 · see citing works
Iron metabolism and the innate immune response to infection
Johnson, E. E., & Wessling-Resnick, M. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2011.10.001 · Cited by 253 · see citing works
“Additionally, the iron transporters Nramp1 and ferroportin have been shown to influence cytokine production and NO production in macrophages [49;62-65] .”
BackgroundSelf-citationHepcidin and Host Defense against Infectious Diseases
Michels, K., Nemeth, E., Ganz, T., & Mehrad, B. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004998 · Cited by 205 · see citing works
Nairz, M., Schleicher, U., Schroll, A., Sonnweber, T., Theurl, I., Ludwiczek, S., Talasz, H., Brandacher, G., Moser, P. L., Muckenthaler, M. U., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121946 · Cited by 204 · see citing works
The Role of Iron in the Immune Response to Bacterial Infection
Cherayil, B. J. (2011) · Immunologic Research · doi:10.1007/s12026-010-8199-1 · Cited by 191 · see citing works
Self-citationIron in immune cell function and host defense
Haschka, D., Hoffmann, A., & Weiss, G. (2021) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.12.005 · Cited by 188 · see citing works
Host-Directed Therapeutics for Tuberculosis: Can We Harness the Host?
Hawn, T. R., Matheson, A. I., Maley, S. N., & Vandal, O. H. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00032-13 · Cited by 150 · see citing works
Nramp1 and Other Transporters Involved in Metal Withholding during Infection
Wessling-Resnick, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.643973 · Cited by 136 · see citing works
Self-citationIron and innate antimicrobial immunity-depriving the pathogen, defending the host
Nairz, M., Dichtl, S., Schroll, A., Haschka, D., Tymoszuk, P., Theurl, I., & Weiss, G. (2018) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2018.03.007 · Cited by 123 · see citing works
Role of iron in the pathogenesis of respiratory disease
Ali, M. K., Kim, R., Karim, R., Mayall, J., Martin, K. L., Shahandeh, A., Abbasian, F., Starkey, M. R., Loustaud-Ratti, V., Johnstone, D. M., et al. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.05.003 · Cited by 112 · see citing works
Biology of Anemia: A Public Health Perspective
Brittenham, G. M., Moir-Meyer, G., Abuga, K. M., Datta-Mitra, A., Cerami, C., Green, R., Pasricha, S., & Atkinson, S. H. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.07.018 · Cited by 122 · see citing works
Halabi, W. J., Nguyen, V., Carmichael, J. C., Pigazzi, A., Stamos, M. J., & Mills, S. (2013) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2013.05.028 · Cited by 88 · see citing works
Understanding How Minerals Contribute to Optimal Immune Function
Ştefanache, A., Lungu, I. I., Butnariu, I.-A., Călin, G., Guțu, C., Marcu, C., Grierosu, C., Goroftei, E. R. B., Duceac, L.-D., Dabija, M. G., et al. (2023) · Journal of Immunology Research · doi:10.1155/2023/3355733 · Cited by 91 · see citing works
Cellular metabolism of tumor‐associated macrophages – functional impact and consequences
Rabold, K., Netea, M. G., Adema, G. J., & Netea-Maier, R. T. (2017) · FEBS Letters · doi:10.1002/1873-3468.12771 · Cited by 75 · see citing works
Isanaka, S., Aboud, S., Mugusi, F., Bosch, R. J., Willett, W. C., Spiegelman, D., Duggan, C., & Fawzi, W. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037350 · Cited by 67 · see citing works
3D Cancer Models: Depicting Cellular Crosstalk within the Tumour Microenvironment
Franchi-Mendes, T., Eduardo, R., Domenici, G., & Brito, C. (2021) · Cancers · doi:10.3390/cancers13184610 · Cited by 57 · see citing works
Iron in intracellular infection: to provide or to deprive?
Silva-Gomes, S., Vale-Costa, S., Appelberg, R., & Gomes, M. S. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00096 · Cited by 51 · see citing works
Paesano, R., Natalizi, T., Berlutti, F., & Valenti, P. (2012) · Pathogens and Global Health · doi:10.1179/2047773212y.0000000043 · Cited by 42 · see citing works
Yang, S., Deng, Q., Sun, L., Dong, K., Li, Y., Wu, S., & Huang, R. (2019) · The FASEB Journal · doi:10.1096/fj.201900883rr · Cited by 40 · see citing works
Iron Supplementation Therapy, A Friend and Foe of Mycobacterial Infections?
Agoro, R., & Mura, C. (2019) · Pharmaceuticals · doi:10.3390/ph12020075 · Cited by 41 · see citing works
Hepcidin, an overview of biochemical and clinical properties
Rauf, A., Shariati, M. A., Khalil, A. A., Bawazeer, S., Heydari, M., Plygun, S., Laishevtcev, A. I., Hussain, M. B., Alhumaydhi, F. A., & Aljohani, A. S. M. (2020) · Steroids · doi:10.1016/j.steroids.2020.108661 · Cited by 40 · see citing works
Advances in Ferritin Physiology and Possible Implications in Bacterial Infection
Gehrer, C. M., Mitterstiller, A., Grubwieser, P., Meyron‐Holtz, E. G., Weiß, G., & Nairz, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054659 · Cited by 40 · see citing works
Lipocalin-2 Functions as Inhibitor of Innate Resistance to Mycobacterium tuberculosis
Dahl, S. L., Woodworth, J. S., Lerche, C. J., Cramer, E. P., Nielsen, P. R., Moser, C. E., Thomsen, A. R., Borregaard, N., & Cowland, J. B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02717 · Cited by 37 · see citing works
Yamane, T., Kanamori, Y., Sawayama, H., Yano, H., Nita, A., Ohta, Y., Hinokuma, H., Maeda, A., Iwai, A., Matsumoto, T., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.156802 · Cited by 33 · see citing works
Symeonidis, A. S., & Marangos, M. N. (2012) · InTech eBooks · doi:10.5772/34760 · Cited by 33 · see citing works
Kallianpur, A. R., Jia, P., Ellis, R. J., Zhao, Z., Bloss, C. S., Wen, W., Marra, C. M., Hulgan, T., Simpson, D. M., Morgello, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103123 · Cited by 33 · see citing works
Brown, D. E., Nick, H. J., McCoy, M. W., Moreland, S. M., Stepanek, A. M., Benik, R., O'Connell, K. E., Pilonieta, M. C., Nagy, T. A., & Detweiler, C. S. (2015) · Infection and Immunity · doi:10.1128/iai.02863-14 · Cited by 31 · see citing works
Effect of ferroportin polymorphism on iron homeostasis and infection
Kasvosve, I. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.11.013 · Cited by 32 · see citing works
Rapid removal of phagosomal ferroportin in macrophages contributes to nutritional immunity
Flannagan, R. S., Farrell, T. J., Trothen, S. M., Dikeakos, J. D., & Heinrichs, D. E. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020002833 · Cited by 25 · see citing works
All trans retinoic acid as a host-directed immunotherapy for tuberculosis
Bahlool, A. Z., Grant, C., Cryan, S., Keane, J., & O’Sullivan, M. P. (2022) · Current Research in Immunology · doi:10.1016/j.crimmu.2022.03.003 · Cited by 25 · see citing works
Ng, S., Lee, C., Ng, A., Ng, S., Arcuri, F., House, M. D., & Norwitz, E. R. (2023) · Reproductive Biology · doi:10.1016/j.repbio.2023.100816 · Cited by 19 · see citing works
Harrington-Kandt, R., Stylianou, E., Eddowes, L. A., Lim, P. J., Stockdale, L. K., Pinpathomrat, N., Bull, N. C., Pasricha, J., Ulaszewska, M., Beglov, Y., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191038 · Cited by 20 · see citing works
Syal, K., Chakraborty, S., Bhattacharyya, R., & Banerjee, D. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2014.12.022 · Cited by 17 · see citing works
Stealing Survival: Iron Acquisition Strategies of Mycobacterium tuberculosis.
Shankar, G., & Akhter, Y. (2024) · Biochimie · doi:10.1016/j.biochi.2024.06.006 · Cited by 12 · see citing works
Baker, M. A., Wilson, D., Wallengren, K., Sandgren, A., Iartchouk, O., Broodie, N., Goonesekera, S. D., Sabeti, P. C., & Murray, M. B. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis026 · Cited by 15 · see citing works
Self-citationKuo, C.-H. S., Liu, C., Pavlidis, S. P., Lo, Y.-L., Wang, Y., Chen, C., Ko, H., Chung, F., Lin, T.-Y., Wang, T., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00232 · Cited by 14 · see citing works
Tashiro, K., Yamamoto, M., Ushio, R., Kobayashi, N., Sato, T., Kudo, M., & Kaneko, T. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.06.023 · Cited by 12 · see citing works
The role of iron in immunity and inflammation: implications for the response to infection
Kuvibidila, S. R., Baliga, S. B., Chandra, L. C., & French, C. (2013) · Elsevier eBooks · doi:10.1533/9780857095749.2.193 · Cited by 11 · see citing works
Leal-Sena, J. A., dos Santos, J. L., dos Santos, T. A. R., de Andrade, E. M., Mendes, T. A. D. O., Santana, J. O., Mineo, T. W. P., Mineo, J. R., Cunha-Junior, J. P., & Pirovani, C. P. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-8759-1 · Cited by 10 · see citing works
Hepcidin mediated iron homoeostasis as immune regulator in visceral leishmaniasis patients
Singh, B., Singh, S. S., & Sundar, S. (2018) · Parasite Immunology · doi:10.1111/pim.12601 · Cited by 8 · see citing works
Mycobacterium aviumComplex Infection in a Patient with Sickle Cell Disease and Severe Iron Overload
Shemisa, K., Jafferjee, N., Thomas, D. L., Jacobs, G. H., & Meyerson, H. J. (2014) · Case Reports in Infectious Diseases · doi:10.1155/2014/405323 · Cited by 8 · see citing works
Ruetten, M., Steinmetz, H. W., Thiersch, M., Kik, M. J. L., Vaughan, L., Altamura, S., Muckenthaler, M. U., & Gassmann, M. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.596379 · Cited by 7 · see citing works
Cikomola, J. C., Vandepoele, K., Katchunga, P. B., Kishabongo, A. S., Padalko, E. Y., Speeckaert, M. M., & Delanghe, J. (2016) · Acta Tropica · doi:10.1016/j.actatropica.2016.07.011 · Cited by 6 · see citing works
Panda, S., Faisal, S., Kumar, K. S., Seelan, D. M., Sharma, A., Gupta, N. K., Datta, S. K., & Singh, A. (2021) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-020-00947-w · Cited by 7 · see citing works
Chen, S., Ma, J., Tang, J., Yang, Y., Zhou, S., & Feng, P. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1658280 · Cited by 6 · see citing works
Enfeksiyon Hastalıklarında Ferroptozun Rolü
Işkın, A. E., & Budak, F. (2023) · Uludağ Üniversitesi Tıp Fakültesi Dergisi · doi:10.32708/uutfd.1337979 · Cited by 2 · see citing works
Antioxidant Therapeutic Defenses Toward Redox Biology and Oxidative Stress
Madkour, L. H. (2020) · Nanomedicine and nanotoxicology · doi:10.1007/978-3-030-37297-2_12 · Cited by 2 · see citing works
Effects of interactions between antioxidant defense therapy and ROS
Madkour, L. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-822481-6.00023-2 · Cited by 1 · see citing works
Moideen, K., Gunasekaran, H., Loukrakpam, B., Ahamed, S. F., Kumar, N. P., Rajendran, A., Bethunaickan, R., & Babu, S. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1666416 · Cited by 1 · see citing works
Effects of Oxidative Stress on J774 Macrophages
Chessier, K. (2014) · Carroll Collected (John Carroll University)
Characterizing Ferroportin Trafficking in Macrophages During Phagocytosis
Farrell, T. J. (2017) · Scholarship@Western (Western University)
Does iron-deficiency anemia affect M1 macrophage activation and inflammation?
Karahan, İ., Çi̇fci̇, A., & Badem, N. D. (2020) · Acta Medica Alanya · doi:10.30565/medalanya.706592
Iron Uptake in Host Defense Against Pneumonia
Michels, K. R. (2017) · doi:10.18130/v3465h
Kathamuthu, G. R., Rajamanickam, A., Sridhar, R., Baskaran, D., & Babu, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.999614
The acute phase response and sickness in dogs
Tizard, I. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23681-5.00005-6
Tizard, I. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-29178-4.00005-8
Costa, M., Pottier, M., Jacob, M., Zarnitzky, P., Segain, B., Figeac, M., Sebda, S., Leprêtre, F., Meresse, B., Demaret, J., et al. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf004
Tizard, I. R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44863-8.00006-5
- Authors
- Johnson, E. E., Sandgren, A., Cherayil, B. J., Murray, M., & Wessling-Resnick, M.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, Massachusetts 02115
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2010-12
- Volume
- 78
- Issue
- 12
- Pages
- 5099-5106
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- PMC
- PMC2981308
- OpenAlex
- W2118427665
- Cited by
- 68
- References
- 59
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 7 · 2019: 3 · 2018: 6 · 2017: 4 · 2016: 4 · 2015: 6 · 2014: 4 · 2013: 7 · 2012: 6
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Infection and Immunity (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (5t32es007155-24, ES014638)
- National Institute of Allergy and Infectious Diseases (R21AI068077, R21 AI06519)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK064750, T90DK070078, P30DK043351, P30DK040561)
- National Institute of Environmental Health Sciences (T32-ES007155, R01ES014638)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- ferroportin, iron metabolism, nitric oxide production, inducible nitric oxide synthase, Mycobacterium tuberculosis, lipopolysaccharide, interferon-gamma, iron efflux, bacterial clearance, J774 macrophages
- MeSH terms
- Ferroportin, Animals, Cell Line, Gene Expression Regulation, Immunity, Cellular, Macrophages, Mycobacterium tuberculosis, Nitric Oxide, Tuberculosis, Blotting, Western, Polymerase Chain Reaction, NF-kappa B, Nitric Oxide Synthase, Cation Transport Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review